Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.
Wendling, Daniel
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology. [electronic resource] - The Journal of rheumatology Dec 2012 - 2327-31 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1499-2752
10.3899/jrheum.120201 doi
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis, Psoriatic--drug therapy
C-Reactive Protein--analysis
Drug Substitution
Female
France
Health Status
Humans
Joints--drug effects
Male
Middle Aged
Registries
Retrospective Studies
Rituximab
Severity of Illness Index
Spondylitis, Ankylosing--drug therapy
Treatment Outcome
Young Adult
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology. [electronic resource] - The Journal of rheumatology Dec 2012 - 2327-31 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1499-2752
10.3899/jrheum.120201 doi
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antirheumatic Agents--therapeutic use
Arthritis, Psoriatic--drug therapy
C-Reactive Protein--analysis
Drug Substitution
Female
France
Health Status
Humans
Joints--drug effects
Male
Middle Aged
Registries
Retrospective Studies
Rituximab
Severity of Illness Index
Spondylitis, Ankylosing--drug therapy
Treatment Outcome
Young Adult